United Therapeutics (UTHR) Other financing activities (2016 - 2025)
United Therapeutics' Other financing activities history spans 16 years, with the latest figure at $11.5 million for Q2 2025.
- On a quarterly basis, Other financing activities changed N/A to $11.5 million in Q2 2025 year-over-year; TTM through Dec 2025 was $11.5 million, a 325.93% increase, with the full-year FY2025 number at $11.5 million, up 325.93% from a year prior.
- Other financing activities hit $11.5 million in Q2 2025 for United Therapeutics, up from $2.7 million in the prior quarter.
- Over the last five years, Other financing activities for UTHR hit a ceiling of $11.5 million in Q2 2025 and a floor of $2.7 million in Q1 2023.
- Historically, Other financing activities has averaged $6.1 million across 4 years, with a median of $5.1 million in 2022.
- Biggest five-year swings in Other financing activities: tumbled 64.0% in 2023 and later changed 0.0% in 2024.
- Tracing UTHR's Other financing activities over 4 years: stood at $7.5 million in 2022, then tumbled by 64.0% to $2.7 million in 2023, then changed by 0.0% to $2.7 million in 2024, then surged by 325.93% to $11.5 million in 2025.
- Business Quant data shows Other financing activities for UTHR at $11.5 million in Q2 2025, $2.7 million in Q1 2024, and $2.7 million in Q1 2023.